The interleukin-1 family

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 565-576

  Roux Lombard, Pascale ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

IL 1 receptor; IL 1 receptor antagonist; Interleukin 1

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA;

CYTOKINE PRODUCTION; GENE EXPRESSION; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; GENE EXPRESSION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; SOLUBILITY;

EID: 0032409837     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Aarden L A, Brunner T K, Cerrottini J C, Dayer J M, De Weck A L, Dinarello C A, Di Sabato G, Farrar J J, Gery I, Gillis S, Handschumacher R E, Henney C S, Hoffmann M K, Koopman W J, Krane S M, Lachman L B, Lefkowits I, Mishell R I, Mizel S B, Oppenheim J J, Paetkau V, Plate J, Rollinghoff M, Rosenstreich D, Rosenthal A S, Rosenwasser L J, Schimpl A, Shim H S, Simon P L, Smith K A, Wagner H, Watson J D, Wecker E, Wood D D. 1979. Revised nomenclature for antigen-non specific T cell proliferation helper factors (letter). J. Immunol. 123: 2928.
2. Webb A C, Collins K L, Auron P E, Eddy R L, Nakai H, Byers M G, Haley W M, Shows T B. 1986. Interleukin-1 gene assigned to long arm of human chromosom 2. Lymphokine Res. 5: 77.
3. Dinarello C A. 1994. The interleukin-1 family: 10 years of discovery. (Review) FASEB J. 8: 1314.
4. Auron P E, Webb A C, Rosenwasser L J, Mucci S F, Rich A, Wolff S M, Dinarello C A. 1984. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc. Natl. Acad. Sci. USA 81: 7907.
5. March C J, Mosley B, Larsen A, Cerretti D P, Braedt G, Price V, Gillis S, Henney C S, Kronheim S R, Grabstein K, et al. 1985. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315: 641.
6. Lomedico P T, Gubler U, Hellmann C P, Dukovich M, Giri J G, Pan Y C, Collier K, Semionow R, Chua A O, Mizel S B. 1984. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312: 458.
7. Gubler U, Chua A O, Stern A S, Hellmann C P, Vitek M P, De Chiara T M, Benjamin W R, Collier K J, Dukovich M, Familletti P C, et al. 1986. Recombinant human interleukin-1 alpha: purification and biological characterization. J. Immunol. 136: 2492.
8. Clark B D, Collins K L, Gandy M S, Webb A C, Auron P E. 1986. Genomic sequence for human prointerleukin-1beta: possible evolution from a reverse transcribed prointerleukin-1alpha gene [published erratum appears in Nucleic Acids Res. 1987 Jan 26; 15(2): 868]. Nucleic Acids Res. 14: 7897.
9. Furutani Y, Notake M, Fukui T, Ohue M, Nomura H, Yamada M, Nakamura S. 1986. Complete nucleolide sequence of the gene for human interleukin-1alpha [published erratum appears in Nucleic Acids Res. 1986 Jun 25; 14(12): 5124]. Nucleic Acids Res. 14: 3167.
10. Di Giovine F S, Takhsh E, Blakemore A I, Duff G W. 1992. Single base polymorphism at - 511 in the human interleukin-1beta gene (IL-1beta). Hum. Mol. Genet. 1: 450.
11. Bailly S, Di Giovine F S, Blakemore A I, Duff G W. 1993. Genetic polymorphism of human interleukin-1α. Eur. J. Immunol. 23: 1240.
12. McDowell T L, Symons J A, Ploski R, Forre O, Duff G W. 1995. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum. 38: 221.
13. Di Giovine F S, Crane A, Gough A, De Vries N, van de Putte L B A, Emery P, Duff G W. 1994. A genetic polymorphism in the IL-1β gene is associated with joint erosions in rheumatoid arthritis. Cytokine 6: 545 (abstract).
14. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. 1992. A Taql polymorphism in the human interleukin-1beta (IL-1beta) gene correlates with IL-1beta secretion in vitro. Eur. J. Clin. Invest. 22: 396.
15. Murzin A G, Lesk A M, Chothia C. 1992. Beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1beta and 1alpha and fibroblast growth factors. J. Mol. Biol. 223: 531.
16. Nanduri V B, Hulmes J D, Pan Y C, Kilian P L, Stern A S. 1991. The role of arginine residues in interleukin-1 receptor binding. Biochim. Biophys. Acta 1118: 25.
17. Shirakawa F, Saito K, Bonagura C A, Galson D L, Fenton M J, Webb A C, Auron P E. 1993. The human prointerleukin-1beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell. Biol. 13: 1332.
18. Furutani Y. 1994. Molecular studies on interleukin-1α. (Review) Eur. Cytokine Netw. 5: 533.
19. Auron P E, Webb A C. 1994. Interleukin-1: a gene expression system regulated at multiple levels. (Review) Eur. Cytokine Netw. 5: 573.
20. Tsukada J, Saito K, Waterman W R, Webb A C, Auron P E. 1994. Transcription factors NF-IL-6 and CREB recognize a common essential site in the human prointerleukin-1beta gene. Mol. Cell. Biol. 14: 7285.
21. Buras J A, Monks B G, Fenton M J. 1994. The NF-βA-binding element, not an overlapping NF-IL-6-binding element, is required for maximal IL-1β gene expression. J. Immunol. 152: 4444.
22. Fenton M J, Lodie T, Buras J. 1994. NF-βA is identical to the ETS family member PU.I and is structurally altered following LPS activation. Cytokine 6: 558.
23. Dinarello C A. 1996. Biologic basis for interleukin-1 in disease. (Review) Blood 87: 2095.
24. Dinarello C A. 1991. Interleukin-1 and interleukin-1 antagonism. (Review) Blood 77: 1627.
25. Sisson S D, Dinarello C A. 1988. Production of interleukin-1 alpha, interleukin-1beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony stimulating factor. Blood 72: 1368.
26. Ucla C, Roux-Lombard P, Fey S, Dayer J M, Mach B. 1990. Interferon gamma drastically modifies the regulation of interleukin-1 genes by endotoxin in U937 cells. J. Clin. Invest. 85: 185.
27. Collart M A, Belin D, Vassalli J D, De Kossodo S, Vassalli P. 1986. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113.
28. Nawroth P P, Bank I, Handley D, Cassimeris J, Chess L, Stern D. 1986. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1. J. Exp. Med. 163: 1363.
29. Dinarello C A, Cannon J G, Wolff S M, Bernheim H A, Beutler B, Cerami A, Figari I S, Palladino M A Jr, O'Connor J V 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J. Exp. Med. 163: 1433.
30. Le J M, Weinstein D, Gubler U, Vilcek J. 1987. Induction of membrane-associated interleukin-1 by tumor necrosis factor in human fibroblasts. J. Immunol. 138: 2137.
31. Warner S J, Auger K R, Libby P. 1987. Interleukin 1 induces interleukin-1. II. Recombinant human interleukin-1 induces interleukin-1 production by adult human vascular endothelial cells. J. Immunol. 139: 1911.
32. Dinarello C A, Ikejima T, Warner S J, Orencole S F, Lonnemann G, Cannon J G, Libby P. 1987. Interleukin-1 induces interleukin-1. I. Induction of circulating interleukin-1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 139: 1902.
33. Dinarello C A. 1989. Interleukin-1 and its biologically related cytokines. (Review) Adv. Immunol. 44: 153.
34. Fenton M J, Vermeulen M W, Clark B D, Webb A C, Auron P E. 1988. Human pro-IL-1beta gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 140: 2267.
35. Schindler R, Ghezzi P, Dinarello C A. 1990. IL-1 induces IL-1. IV. IFN-γ supresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 144: 2216.
36. Kaspar R L, Gehrke L. 1994. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1 beta mRNA show unequal IL-1beta protein accumulation but similar polyribosome profiles. J. Immunol. 153: 277.
37. Schindler R, Clark B D, Dinarello C A. 1990. Dissociation between interleukin-1β mRNa and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 265: 10232.
38. Vey E, Zhang J H, Dayer J M. 1992. IFN-gamma and I, 25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J. Immunol. 149: 2040.
39. Isler P, Vey E, Zhang J H, Dayer J M. 1993. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur. Cytokine Netw. 4: 15.
40. Vannier E, Miller L C, Dinarello C A. 1992. Coordinated anti-inflammatory effects of interleukin-4: interleukin-4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 89: 4076.
41. Hart P H, Vitti V F, Burgess D R, Whitty G A, Piccoli D S, Hamilton J A. 1989. Potential anti-inflammatory effects of interleukin-4: suppression of human monocyte tumor necrosis factor, interleukin-1 and prostaglandin E2. Proc. Natl. Acad. Sci. USA 86: 3803.
42. De Waal Malefyt R, Abrams J, Bennett B, Figdor C G, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
43. Wang P, Wu P, Siegel M I, Egan R W, Billah M M. 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153: 811.
44. Chernoff A E, Granowitz E V, Shapiro L, Vannier E, Lonnemann G, Angel J B, Kennedy J S, Rabson A R, Wolff S M, Dinarello C A. 1995. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154: 5492.
45. Chantry D, Turner M, Abney E, Feldmann M. 1989. Modulation of cytokine production by transforming growth factor beta. J. Immunol. 142: 4295.
46. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark S C, Dinarello C A. 1990. Correlations and interactions in the production of interleukin-6 (IL-6). IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75: 40.
47. Endres S, Ghorbani R, Kelley V E, Georgilis K, Lonnemann G, van der Meer J W, Cannon J G, Rogers T S, Klempner M S, Weber P C, et al. 1989. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320: 265.
48. Molvig J, Pociot F, Worsaae H, Wogensen L D, Back L, Christensen P, Mandrup-Poulsen T, Andersen K, Madsen P, Dyerberg J, et al. 1991. Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand. J. Immunol. 34: 399.
49. Meydani S N, Lichtenstein A H, Cornwall S, Meydani M, Goldin B R, Rasmussen H, Dinarello C A, Schaefer E J. 1993. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J. Clin. Invest. 92: 105.
50. Besedovsky H, del Rey A, Sorkin E, Dinarello C A. 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652.
51. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H. 1987. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238: 524.
52. Mosley B, Urdal D L, Prickett K S, Larsen A, Cosman D, Conlon P J Gillis S, Dower S K. 1987. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J. Biol. Chem. 262: 2941.
53. Wakabayashi G, Gelfand J A, Jung W K, Connolly R J, Burke J F, Dinarello C A. 1991. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J. Clin. Invest. 87: 1925.
54. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim J J, Matsushima K. 1990. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin-1 alpha. Proc. Natl. Acad. Sci. USA 87: 5548.
55. Kavita U, Mizel S B. 1995. Differential sensitivity of interleukin-1α and -β precursor proteins to cleavage by calpain, a calcium dependent protease. J. Biol. Chem. 270: 27758.
56. Hauser C, Saurat J H, Schmitt A, Jaunin F, Dayer J M. 1986. Interleukin-1 is present in normal human epidermis. J. Immunol. 136: 3317.
57. Maier J A, Voulalas P, Roeder D, Maciag T. 1990. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 249: 1570.
58. Weitzmann M N, Savage N. 1992. Nuclear internalisation and DNA binding activities of interleukin-1, interleukin-1 receptor and interleukin-1/receptor complexes. Biochem. Biophys. Res. Commun. 187: 1166.
59. Mizel S B, Kilian P L, Lewis J C, Paganelli K A, Chizzonite R A. 1987. The interleukin-1 receptor. Dynamics of interleukin-1 binding and internalization in T cells and fibroblasts. J. Immunol. 138: 2906.
60. Curtis B M, Widmer M B, De Roos P, Qwarnstrom E E. 1990. IL-1 and its receptor are translocated to the nucleus. J. Immunol. 144: 1295.
61. Stevenson F T, Bursten S L, Fanton C, Locksley R M, Lovett D H. 1993. The 31 kDa precursor of interleukin-1α is myristoylated on specific lysines within the 16 kDa N-terminal propiece. Proc. Natl. Acad. Sci. USA 90: 7245.
62. Brody D T, Durum S K. 1989. Membrane IL-1: IL-1alpha precursor binds to the plasma membrane via a lectin-like interaction. J. Immunol. 143: 1183.
63. Kaplanski G, Farnarier C, Kaplanski S, Porat R, Shapiro L, Bongrand P, Dinarello C A. 1994. Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 84: 4242.
64. Jobling S A, Auron P E, Gurka G, Webb A C, McDonald B, Rosenwasser L J, Gehrke L. 1988. Biological activity and receptor binding of human prointerleukin-1beta and subpeptides. J. Biol. Chem. 263: 16372.
65. Beuscher H U, Gunther C, Rollinghoff M. 1990. IL-1beta is secreted by activated murine macrophages as biologically inactive precursor. J. Immunol. 144: 2179.
66. Black R A, Kronheim S R, Cantrell M, Deeley M C, March C J, Prickett K S, Wignall J, Conlon P J, Cosman D, Hopp T P, et al. 1988. Generation of biologically active interleukin-1beta by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263: 9437.
67. Cerretti D P, Kozlosky C J, Mosley B, Nelson N, van Ness K, Greenstreet T A, March C J, Kronheim S R, Druck T, Cannizzaro L A, et al. 1992. Molecular cloning of the interleukin-1beta converting enzyme. Science 256: 97.
68. Thornberry N A, Bull H G, Calaycay J R, Chapman K T, Howard A D, Kostura M J, Miller D K, Molineaux S M, Weidner J R, Aunins J, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1beta processing in monocytes. Nature 356: 768.
69. Howard A D, Kostura M J, Thornberry N, Ding G J, Limjuco G, Weidner J, Salley J P, Hogquist K A, Chaplin D D Mumford R A, Schmidt J A, Tocci M J. 1991. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31 kDa IL-1α. J. Immunol. 147: 2964.
70. Wilson K P, Black J A, Thomson J A, Kim E E, Griffith J P, Navia M A, Murcko M A, Chambers S P, Aldape R A, Raybuck S A, Livingston D J. 1994. Structure and mechanism of interleukin-1β converting enzyme. Nature 370: 270.
71. Gu Y, Wu J, Faucheu C, Lalanne J L, Diu A, Livingston D J, Su M S. 1995. Interleukin-1beta converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J. 14: 1923.
72. Wu M X, Daley J F, Rasmussen R A, Schlossman S F. 1995. Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc. Natl. Acad. Sci. USA 92: 1525.
73. Yuan J, Shaham S, Ledoux S, Ellis H M, Horvitz H R. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1beta-converting enzyme. Cell 75: 641.
74. Miura M, Zhu H, Rotello R, Hartwieg E A, Yuan J. 1993. Induction of apoptosis in fibroblasts by IL-1beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653.
75. Faucheu C, Diu A, Chan A W, Blanchet A M, Miossec C, Herve F, Collard-Dutilleul V, Gu Y, Aldape R A, Lippke J A, et al. 1995. A novel human protease similar to the interleukin-1beta converting enzyme induces apoptosis in transfected cells. EMBO J. 14: 1914.
76. Kuida K, Lippke J A, Ku G, Harding M W, Livingston D J, Su M S, Flavell R A. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000.
77. Patel T, Gores G J, Kaufmann S H. 1996. The role of proteases during apoptosis. (Review) FASEB J. 10: 587.
78. Friedlander R M, Gagliardini V, Rotello R J, Yuan J. 1996. Functional role of interleukin-1β (IL-1β) in IL-1β-converting enzyme-mediated apoptosis. J. Exp. Med. 184: 717.
79. Balavoine J F, De Rochemonteix B, Williamson K, Seckinger P, Cruchaud A, Dayer J M. 1986. Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin-1 and inhibitor(s). J. Clin. Invest. 78: 1120.
80. Seckinger P, Williamson K, Balavoine J F, Mach B, Mazzei G, Shaw A, Dayer J M. 1987. A urine inhibitor of interleukin-1 activity affects both interleukin-1alpha and 1beta but not tumor necrosis factor alpha. J. Immunol. 139: 1541.
81. Arend W P, Joslin F G, Massoni R J. 1985. Effects of immune complexes on production by human monocytes of interleukin-1 or an interleukin-1 inhibitor. J. Immunol. 134: 3868.
82. Eisenberg S P, Evans R J, Arend W P, Verderber E, Brewer M T, Hannum C H, Thompson R C. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341.
83. Carter D B, Deibel M R, Jr., Dunn C J, Tomich C S, Laborde A L, Slightom J L, Berger A E, Bienkowski M J, Sun F F, McEwan R N, et al. 1990. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344: 633.
84. Seckinger P, Isaaz S, Dayer J M. 1988. A human inhibitor of tumor necrosis factor alpha. J. Exp. Med. 167: 1511.
85. Hannum C H, Wilcox C J, Arend W P, Joslin F G, Dripps D J, Heimdal P L, Armes L G, Sommer A, Eisenberg S P, Thompson R C. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343: 336.
86. Haskill S, Martin G, van Le L, Morris J, Peace A, Bigler C F, Jaffe G J, Hammerberg C, Sporn S A, Fong S, et al. 1991. cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88: 3681.
87. Butcher C, Steinkasserer A, Tejura S, Lennard A C. 1994. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J. Immunol. 153: 701.
88. Hammerberg C, Arend W P, Fisher G J, Chan L S, Berger A E, Haskill J S, Voorhees J J, Cooper K D. 1992. Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J. Clin. Invest. 90: 571.
89. Arend W P. 1993. Interleukin-1 receptor antagonist. (Review) Adv. Immunol. 54: 167.
90. Muzio M, Polentarutti N, Sironi M, Poli G, De Gioia L, Introna M, Mantovani A, Colotta F. 1995. Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist. J. Exp. Med. 182: 623.
91. Vigers G P, Caffes P, Evans R J, Thompson R G, Eisenberg S P, Brandhuber B J. 1994. X-ray structure of interleukin-1 receptor antagonist at 2.0-Å resolution. J. Biol. Chem. 269: 12874.
92. Evans R J, Bray J, Childs J D, Vigers G P, Brandhuber B J, Skalicky J J, Thompson R C, Eisenberg S P. 1995. Mapping receptor binding sites in interleukin-(IL)-1 receptor antagonist and IL-1β by site-directed mutagenesis. Identification of a single site in IL-1Ra and two sites in IL-1β. J. Biol. Chem. 270: 11477.
93. Lennard A C. 1995. Interleukin-1 receptor antagonist. (Review) Crit. Rev. Immunol. 15: 77.
94. Smith M F Jr, Eidlen D, Arend W P, Gutierrez-Hartmann A. 1994. LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J. Immunol. 153: 3584.
95. Lennard A, Gorman P, Carrier M, Griffiths S, Scotney H, Sheer D, Solari R. 1992. Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 4: 83.
96. Tarlow J K, Blakemore A I, Lennard A, Solari R, Hughes H N, Steinkasserer A, Duff G W. 1993. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91: 403.
97. Mansfield J C, Holden H, Tarlow J K, Di Giovine F S, McDowell T L, Wilson A G, Holdsworth C D, Duff G W. 1994. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106: 637.
98. Bioque G, Crusius J B, Koutroubakis I, Bouma G, Kostense P J, Meuwissen S G, Peña A S. 1995. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102: 379.
99. Blakemore A I, Tarlow J K, Cork M J, Gordon C, Emery P, Duff G W. 1994. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematostis. Arthritis Rheum. 37: 1380.
100. Tarlow J K, Clay F E, Cork M J, Blakemore A I, McDonagh A J, Messenger A G, Duff G W. 1994. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J. Invest. Dermatol. 103: 387.
101. Granowitz E V, Santos A A, Poutsiaka D D, Cannon J G, Wilmore D W, Wolff S M, Dinarello C A. 1991. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338: 1423.
102. Arend W P, Smith M F Jr, Janson R W, Joslin F G. 1991. IL-1 receptor antagonist and IL-1β production in human monocyles are regulated differently. J. Immunol. 147: 1530.
103. Poutsiaka D D, Clark B D, Vannier E, Dinarello C A. 1991. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 78: 1275.
104. Marsh C B, Pope H A, Wewers M D. 1994. Fcgamma receptor cross-linking down-regulates IL-1 receptor antagonist and induces IL-1β in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus. J. Immunol. 152: 4604.
105. Jenkins J K, Arend W P. 1993. Interleukin-1 receptor antagonist production in human monocytes is induced by IL-1 alpha. IL-3, IL-4 and GM-CSF. Cytokine 5: 407.
106. Wahl S M, Costa G L, Corcoran M, Wahl L M, Berger A E. 1993. Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J. Immunol. 150: 3553.
107. Wong H L, Costa G L, Lotze M T, Wahl S M. 1993. Interleukin (IL)-4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J. Exp. Med. 117: 775.
108. Jenkins J K, Malyak M, Arend W P. 1994. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cvtokine Res. 13: 47.
109. Seitz, M, Loetscher P, Dewald B, Towbin H, Gallati H, Baggiolini M. 1995. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur. J. Immunol. 25: 1129.
110. Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A, Colotta F. 1994. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1Ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1Ra in human myelomonocytic cells. Blood 83: 1738.
111. Chizzolini C, Chicheportiche R, Burger D, Dayer J M. 1997. Human Th1 cells preferentially induce interleukin-IL-1β while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur. J. Immunol. 27: 171.
112. Roux-Lombard P, Modoux C, Dayer J M. 1989. Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF. Cytokine 1: 45.
113. Janson R W, Hance K R, Arend W P. 1991. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J. Immunol. 147: 4218.
114. Galve-de Rochemonteix B, Nicod L P, Junod A F, Dayer J M. 1990. Characterization of a specific 20 to 25 kD interleukin-1 inhibitor from cultured human lung macrophages. Am. J. Respir. Cell Mol. Biol. 3: 355.
115. Janson R W, King T E Jr, Hance K R, Arend W P. 1993. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am. Rev. Respir. Dis. 148: 495.
116. Roux-Lombard P, Modoux C, Vischer T, Grassi J, Dayer J M. 1992. Inhibitors of interleukin-1 activity in synovial fluids and in cultured synovial fluid mononuclear cells. J. Rheumatol. 19: 517.
117. Koch A E, Kunkel S L, Chensue S W, Haines G K, Strieter R M. 1992. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin. Immunol. Immunopathol. 65: 23.
118. Moore S A, Strieter R M, Rolfe M W, Standiford T J, Burdick M D, Kunkel S L. 1992. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 6: 569.
119. Ohashi P S, Oehen S, Aichele P, Pircher H, Odermatt B, Herrera P, Higuchi Y, Buerki K, Hengartner H, Zinkernagel R M. 1993. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α. J. Immunol. 150: 5185.
120. Tilg H, Vannier E, Vachino G, Dinarello C A, Mier J W. 1993. Anti-inflammatory properties of hepatic acute phase proteins: preferential induction of interleukin-1 (IL-1) receptor antagonist over IL-1beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178: 1629.
121. Pue C A, Mortensen R F, Marsh C B, Pope H A, Wewers M D. 1996. Acute phase levels of C-reactive protein enhance IL-1β and IL-1Ra production by human blood monocytes but inhibit IL-1β and IL-1Ra production by alveolar macrophages. J. Immunol. 156: 1594.
122. Tilg H, Trehu E, Atkins M B, Dinarello C A, Mier J W. 1994. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83: 113.
123. Gabay C, Smith M F, Eidlen D, Arend W P. 1996. Interleukin-1 receptor antagonist (IL-1Ra) is an acute-phase protein. J. Clin. Invest. 99: 2930.
124. McColl S R, Paquin R, Ménard C, Beaulieu A D. 1992. Human neutrophils produce high levels of the interleukin-1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J. Exp. Med. 176: 593.
125. Re F, Mengozzi M, Muzio M, Dinarello C A, Mantovani A, Colotta F. 1993. Expression of interleukin-1 receptor antagonist (IL-1Ra) by human circulating polymorphonuclear cells. Eur. J. Immunol. 23: 570.
126. Malyak M, Smith M F Jr, Abel A A, Arend W P. 1994. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. J. Clin. Immunol. 14: 20.
127. Jelkmann W E, Fandrey J, Frede S, Pagel H. 1994. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann. NY Acad. Sci. 718: 300.
128. Marie C, Pitton C, Fitting C, Cavaillon J M. 1996. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1Ra production by human neutrophils. Cytokine 8: 147.
129. Chan L S, Hammerberg C, Kang K, Sabb P, Tavakkol A, Cooper K D. 1992. Human dermal fibroblast interleukin-1 receptor antagonist (IL-1Ra) and interleukin-1β (IL-1β) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism. J. Invest. Dermatol. 99: 315.
130. Gruaz-Chatellard D, Baumberger C, Saurat J H, Dayer J M. 1991. Interleukin-1 receptor antagonist in human epidermis and cultured keratinocytes. FEBS Lett. 294: 137.
131. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R A, Ju G. 1995. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270: 13757.
132. Sims J E, Painter S L, Gow I R. 1995. Genomic organization of the type I and type II IL-1 receptors. Cvtokine 7: 483.
133. Shirakawa F, Tanaka Y, Ota T, Suzuki H, Eto S, Yamashita U. 1987. Expression of interleukin-1 receptors on human peripheral T cells. J. Immunol. 138: 4243.
134. Sims J E, March C J, Cosman D, Widmer M B, MacDonald H R, McMahan C J, Grubin C E, Wignall J M, Jackson J L, Call S M, et al. 1988. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585.
135. Stylianou E, O'Neill L A, Rawlinson L, Edbrooke M R, Woo P, Saklatvala J. 1992. Interleukin-1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J. Biol. Chem. 267: 15836.
136. Sims J E, Gayle M A, Slack J L, Alderson M R, Bird T A, Giri J G, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein K H, Dower S K. 1993. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90: 6155.
137. Ye K, Dinarello C A, Clark B D. 1993. Identification of the promoter region of human interleukin-1 type I receptor gene: multiple initiation sites, high G+C content, and constitutive expression. Proc. Natl. Acad. Sci. USA 90: 2295.
138. Takii T, Akahoshi T, Kato K, Hayashi H, Marunouchi T, Onozaki K. 1992. Interleukin-1 up-regulates transcription of its own receptor in a human fibroblast cell line TIG-1: role of endogenous PGE2 and cAMP. Eur. J. Immunol. 22: 1221.
139. Takii T, Hayashi H, Marunouchi T, Onozaki K. 1994. Interleukin-1 down-regulates type I interleukin-1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence ot prostaglandin E2 synthesis. Lympho. Cytokines Res. 13: 213.
140. Dubois C M, Ruscetti F W, Palaszynski E W, Falk L A, Oppenheim J J, Keller J R. 1990. Transforming growth factor beta is a potent inhibitor of interleukin-1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172: 737.
141. Einstein R, Jackson J R, d'Allessio K, Lillquist J S, Sathe G, Porter T, Young P R. 1996. Type I IL-1 receptor : ligand specific conformation differences and the role of glycosylation in ligand binding. Cytokine 8: 206.
142. McMahan C J, Slack J L, Mosley B, Cosman D, Lupton S D, Brunton L L, Grubin C E, Wignall J M, Jenkins N A, Brannan C I, et al. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821.
143. Sims J E, Giri J G, Dower S K. 1994. The two interleukin-1 receptors play different roles in IL-1 actions. (Review) Clin. Immunol. Immunopathol. 72: 9.
144. McKean D J, Podzorski R P, Bell M P, Nilson A E, Huntoon C J, Slack J, Dower S K, Sims J. 1993. Murine T helper cell-2 lymphocytes express type I and type Il IL-1 receptors, but only the type I receptor mediates costimulatory activity. J. Immunol. 151: 3500.
145. Colotta F, Dower S K, Sims J E, Mantovani A. 1994. The type II "decoy" receptor: a novel regulatory pathway for interleukin-1. (Review) Immunol. Today 15: 562.
146. Granowitz E V, Clark B D, Mantilla J, Dinarello C A. 1991. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J. Biol. Chem. 266: 14147.
147. Re F, Sironi M, Muzio M, Matteucci C, Introna M, Orlando S, Penton-Rol G, Dower S K, Sims J E, Colotta F, Mantovani A. 1996. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function. J. Exp. Med. 183: 1841.
148. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J G, Dower S K, Sims J E, Mantovani A. 1993. Interleukin-1 type II receptor: a decoy tarset for IL-1 that is regulated by IL-4. Science 261: 472.
149. Re F, Muzio M, De Rossi M, Polentarutti N, Giri J G, Mantovani A, Colotta F. 1994. The type II "receptor" as a decoy target for interleukin-1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179: 739.
150. Colotta F, Saccani S, Giri J G, Dower S K, Sims J E, Introna M, Mantovani A. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156: 2534.
151. Symons J A, Eastgate J, Duff G W. 1991. Purification and characterization of a novel soluble receptor for interleukin-1. J. Exp. Med. 174: 1251.
152. Arend W P, Malyak M, Smith M F Jr, Whisenand T D, Slack J L, Sims J E, Giri J G, Dower S K. 1994. Binding of IL-1α. IL-1β. and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153: 4766.
153. Orencole S F, Fantuzzi G, Vannier E, Dinarello C A. 1995. Circulating levels of IL-1 soluble receptors in health and after endotoxin or IL-2 administration. Cytokine 7: 642 (abstract).
154. Giri J G, Wells J, Dower S K, McCall C E, Guzman R N, Slack J, Bird T A, Shanebeck K, Grabstein K H, Sims J E, Alderson M R. 1994. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153: 5802.
155. Sims J E, Dower S K. 1994. Interleukin-1 receptors. (Review) Eur. Cytokine Netw. 5: 539.
156. Symons J A, Young P R, Duff G W. 1995. Soluble type II interleukin-1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 92: 1714.
157. Burger D, Chicheportiche R, Giri J G, Dayer J M. 1995. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J. Clin. Invest. 96: 38.
158. Spriggs M K, Hruby D E, Maliszewski C R, Pickup D J, Sims J E, Buller R M, van Slyke J. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71: 145.
159. Alcamí A, Smith G L. 1992. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71: 153.